R&D IVD Senior Project Manager (m/w/d) wanted!

Moving Diagnostic Frontiers in Dermatology

At Dermagnostix, we develop molecular diagnostic tests to support dermatopathologists in achieving precise and objective diagnoses. We create cutting-edge easy to-use molecular diagnostics for dermatology to advance clinical practice and improve therapeutic outcome.

Discover more about us

Need for Precision Diagnostics

Transforming Dermatology Diagnostics for a Healthier Future

Skin diseases are highly relevant. One third of the population suffers from at least one skin condition¹ and incidences of psoriasis² and atopic dermatitis³ have doubled during the past decades.

Novel biologics and small-molecule inhibitors have revolutionized treatment options and created a billion dollar market with 5 of the top 10 global blockbuster drugs targeting dermatological conditions.4

However, advances in therapeutics outpace diagnostics in dermatology, leaving a significant gap in precision care. To fully unlock the potential of modern drugs, we need molecular diagnostics alongside conventional methods.

Dermagnostix closes this gap with plug-and-play molecular diagnostic solutions that seamlessly integrate into clinical workflows. By delivering objective, actionable molecular insights, we empower healthcare professionals to make confident decisions. At Dermagnostix, dermatology is more than skin deep - it’s about transforming lives through personalized care and cutting-edge technology!

References

• Flohr C, Hay R (2021): Putting the burden of skin diseases on the global map. Br J Dermatol 184(2): 189-190.
• Andersen LK, Davis MD (2013): The epidemiology of skin and skin-related diseases: a review of population-based studies performed by using the Rochester Epidemiology Project. Mayo Clinic proceedings 88:1462-7.
• Nutten S (2015): Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 66 Suppl 1:8-16.
• The top 20 drugs by worldwide sales in 2023. (2024, May 28). Fierce Pharma. Accessed February 21, 2025, von https://www.fiercepharma.com/special-reports/top-20-drugs-worldwide-sales-2023
  
  

Book a Demo

Our Solutions For Your Challenges

Discover how our user-friendly solutions can modernize your pathology lab.

Get all your questions answered and enhance diagnostic precision with our products.

More

Explore how our objective molecular solutions increase your diagnostic precision to make the best treatment decisions for your patients. Explore our Point-of-Care product pipeline.

More

Unlock the potential of our innovative diagnostics and see how your investment can drive advancements in medicine. Discover opportunities for growth and impact.

More

Book a meeting

PsorX-LabDisk

PsorX-LabDisk

The First Molecular Test for the Differential Diagnosis of Psoriasis and Eczema

Psoriasis or Eczema? Psoriasiform eczema versus eczematized psoriasis? The difference truely matters with specific treatment options now available for both diseases.

PsorX-LabDisk (CE-IVD) is a groundbreaking molecular diagnostic tool that quantitatively differentiates between psoriasis and eczema by analyzing the expression of two marker genes, NOS2 and CCL27, in the skin. Designed to enhance diagnostic precision, it empowers pathologists and dermatopathologists with accurate, patient-specific molecular insights. By bridging the gap between histological and molecular data, PsorX-LabDisk supports confident clinical decision-making and supports personalized care in dermatology.

Find out more

LabDisk-Analyzer

LabDisk-Analyzer

Precision Meets Automation

The LabDisk-Analyzer is a state-of-the-art diagnostic medical device designed for advanced molecular workflows in pathology and beyond!

This fully automated system streamlines and accelerates molecular workflows – from sample preparation to signal detection – minimizing manual steps and user errors. Its compact, intuitive design supports laboratories in delivering precise results efficiently while complying with IVDR standards, setting a new benchmark for modern molecular diagnostics.

Learn more

LabDisk Product Pipeline

LabDisk Product Pipeline

Novel Molecular Diagnostic Tests for Dermatopathology and Dermatology

The modular LabDisk design enables rapid innovation in molecular diagnostics for complex skin diseases. This technology supports the development of groundbreaking tests such as LymphX, a gene-expression-based diagnostic tool that provides precise differentiation between mycosis fungoides (MF), psoriasis, and eczema. PatternX introduces a new dimension in dermatopathology by identifying molecular patterns that redefine traditional disease classifications, allowing for highly tailored and effective patient treatments. PsorX 2.0 will support dermatologists in the differential diagnoses of psoriasis, eczema, and tinea directly at the Point-of-Care using minimal-invasive sampling methods.

Learn more

Simple Diagnostic Tools for Complex Skin Diseases

Simple

To ensure maximum usability, the user only needs to place the sample into the LabDisk and insert the LabDisk into the Analyzer.

Fast

Results are delivered in only 1-2 hours enabling pathologists and dermatologists to make timely decisions about their patients’ therapies.

Precise

All advantages of centrifugal microfluidics are exploited, enabling reliable, objective and valid results.

Made in Germany

Our technology is developed and produced in Germany meeting all CE-IVD requirements.

Plug-and-Play

Start your analysis directly without the need of any additional validation.

By loading the video, you agree to YouTube's privacy policy.

Learn more

Load video

Always unblock YouTube

Voice of Diagnostic Pioneers

Pathologie Trier

Prof. Dr. Dr. Jörg Kriegsmann

MVZ für Histologie, Zytologie & Molekulare Diagnostik Trier

"Pathology is changing - by using modern methods such as molecular diagnostics in combination with a trained view through the microscope, we achieve greater precision and objectivity and set new quality standards. The innovative Dermagnostix products are therefore a perfect addition to our service portfolio. The excellent customer service should also be highlighted: if you have any questions or challenges, they will always find a quick solution. As a pioneers in pathological molecular diagnostics, we greatly appreciate the cooperation with Dermagnostix."

Uniklinik Augsburg - 1

University Hospital Augsburg -Dermatohistopathology Laboratory

Franziska Augustiner

"Using the Dermagnostix system, including the LabDisk-Analyzer and PsorX-LabDisk, has significantly improved our ability to differentiate between psoriasis and eczema diagnoses with more precision. It serves as an excellent diagnostic support tool alongside histology. Implementing the system into our daily lab routine was smooth, and all our staff found it easy to understand."

Kristian Reich

Prof. Kristian Reich, M.D., Ph.D

Specialist in dermatology and venereology

Professor for translational research of inflammatory skin diseases

“The molecular diagnostic possibilities Dermagnostix offers will be the future in pattern diagnostics of dermatological diseases and ultimately treatment selection. Great to see how the platform automizes complex procedures in a closed and fast system.“

Biopticka

Prof. Denisa Kacerovská, M.D., PhD

Bioptická laboratoř s.r.o. Pilsen, Czech Republic

“Most of my routine cases are inflammatory diseases, especially eczema and psoriasis. Most of them are straightforward in diagnoses. However, some cause diagnostic dilemmas. In these cases, the PsorX-LabDisk is extremely useful in supporting my histological diagnosis quickly and easily. Furthermore, its user-friendly handling saves me time compared to other molecular biological tests.“

Uniklinik Augsburg - 2

University Hospital Augsburg -Dermatohistopathology Laboratory

Franziska Augustiner

"We are extremely satisfied with the customer service. Every time we had a question or faced a challenge, support was available by phone or email. The friendly and efficient communication with the Team and the quick problem-solving really stood out to us. We had no concerns about using molecular diagnostics in dermatopathology, as we are an innovative and forward-thinking lab."

Heidepathologie Radeberg

Dr. med. Steffen Jahn

Pathologie an der Dresdner Heide

"The diagnosis of inflammatory skin diseases, especially the differentiation of psoriasis from eczema, is oftentimes difficult, both clinically and histologically. Unfortunately, this often prevents a targeted and effective therapy, even though the disease has often been present for years. With the PsorX-LabDisk we are pleased to be able to offer our patients for the first time a highly specific, molecular pathological and yet uncomplicated solution to this problem."